Correction: Beta-blockers in refractory hypoxemia on venovenous extracorporeal membrane oxygenation: a double-edged sword

Abstract

Correction: Critical Care (2023) 27:360 https://doi.org/10.1186/s13054-023-04648-7

Following publication of the original article [1], the authors identified an errors in Figure 1. It should indicate CO = 0.80 instead of CO = 0.67 in A a) ARPDS patient on V-V ECMO and g/dl instead of mg/dl in A a), b) and c). Both the incorrect and correct Figure 1 are given hereafter.

The incorrect Figure 1:

Fig. 1

A Schematic representation of ECMO flow and cardiac output. Red indicates V-V ECMO flow, and blue indicates cardiac output. For illustrative purposes, recirculation is neglected; a Patient with ARDS and V-V ECMO support. The Q_ECMO/CO ratio is 0.67, with saturation at 100%. DO₂ is 500 ml/min. b The same patient with increased oxygen demand, for example, due to infection and fever. Q_ECMO remains the same while CO is increased. This results in a ratio of 0.40, saturation of 85%, but a significantly increased DO2 of 850 ml/min. c Patient with increased oxygen demand treated with beta-blocker. The higher Q_ECMO/CO ratio improved arterial oxygen saturation, but the DO2 drops to 665 ml/min. B Displays three ARDS patients undergoing V-V ECMO therapy, in whom beta-blockers were titrated based on their effects. The measurements were taken three times each after reaching a steady state

Full size image

The correct Figure 1:

Fig. 1

A Schematic representation of ECMO flow and cardiac output. Red indicates V-V ECMO flow, and blue indicates cardiac output. For illustrative purposes, recirculation is neglected; a Patient with ARDS and V-V ECMO support. The Q_ECMO/CO ratio is 0.80, with saturation at 100%. DO₂ is 500 ml/min. b The same patient with increased oxygen demand, for example, due to infection and fever. Q_ECMO remains the same while CO is increased. This results in a ratio of 0.40, saturation of 85%, but a significantly increased DO2 of 850 ml/min. c Patient with increased oxygen demand treated with beta-blocker. The higher Q_ECMO/CO ratio improved arterial oxygen saturation, but the DO2 drops to 665 ml/min. B Displays three ARDS patients undergoing V-V ECMO therapy, in whom beta-blockers were titrated based on their effects. The measurements were taken three times each after reaching a steady state

Full size image

Figure 1 has been updated in this correction article and the original article [1] has been corrected.

1. Staudacher DL, Wengenmayer T, Schmidt M. Beta-blockers in refractory hypoxemia on venovenous extracorporeal membrane oxygenation: a double-edged sword. Crit Care. 2023;27:360. https://doi.org/10.1186/s13054-023-04648-7.

   Article PubMed PubMed Central Google Scholar

Download references

Authors and Affiliations

1. Interdisciplinary Medical Intensive Care, Faculty of Medicine and Medical Center, University of Freiburg, Hugstetterstrasse 55, 79106, Freiburg, Germany

   Dawid L. Staudacher & Tobias Wengenmayer

2. 1166‑ICAN, Institute of Cardiometabolism and Nutrition, APHP, Hopital Pitie‑ Salpetriere, Service de Medecine Intensive‑Reanimation, Institut de Cardiologie, Sorbonne Universite, Paris, France

   Matthieu Schmidt

Authors

1. Dawid L. StaudacherView author publications

   You can also search for this author in PubMed Google Scholar

2. Tobias WengenmayerView author publications

   You can also search for this author in PubMed Google Scholar

3. Matthieu SchmidtView author publications

   You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dawid L. Staudacher.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

Cite this article

Staudacher, D.L., Wengenmayer, T. & Schmidt, M. Correction: Beta-blockers in refractory hypoxemia on venovenous extracorporeal membrane oxygenation: a double-edged sword. Crit Care 29, 56 (2025). https://doi.org/10.1186/s13054-024-05242-1

Download citation

• Published: 03 February 2025

• DOI: https://doi.org/10.1186/s13054-024-05242-1

Share this article

Anyone you share the following link with will be able to read this content:

Get shareable link

Sorry, a shareable link is not currently available for this article.

Copy to clipboard

Provided by the Springer Nature SharedIt content-sharing initiative